FIBROGEN INC Annual Nonoperating Income (Expense) in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Fibrogen Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2024.
  • Fibrogen Inc Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $205K.
  • Fibrogen Inc Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $5.3M, a 30.3% decline year-over-year.
  • Fibrogen Inc annual Nonoperating Income (Expense) for 2024 was $5.3M, a 30.3% decline from 2023.
  • Fibrogen Inc annual Nonoperating Income (Expense) for 2023 was $7.59M, a 0.03% decline from 2022.
  • Fibrogen Inc annual Nonoperating Income (Expense) for 2022 was $7.6M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.3M -$2.3M -30.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 $7.59M -$2K -0.03% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 $7.6M +$8.67M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 -$1.08M -$6.63M -119% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $5.55M -$10M -64.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $15.5M Jan 1, 2019 Dec 31, 2019 10-K/A 2022-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.